Annual Cash & Cash Equivalents
$29.88 M
+$18.33 M+158.82%
December 1, 2023
Summary
- As of February 8, 2025, OKUR annual cash & cash equivalents is $29.88 million, with the most recent change of +$18.33 million (+158.82%) on December 1, 2023.
- During the last 3 years, OKUR annual cash & cash equivalents has risen by +$18.33 million (+158.82%).
- OKUR annual cash & cash equivalents is now at all-time high.
Performance
OKUR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$60.69 M
+$42.06 M+225.71%
September 30, 2024
Summary
- As of February 8, 2025, OKUR quarterly cash and cash equivalents is $60.69 million, with the most recent change of +$42.06 million (+225.71%) on September 30, 2024.
- OKUR quarterly cash and cash equivalents is now at all-time high.
Performance
OKUR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
OKUR Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +158.8% | - |
| 3 y3 years | +158.8% | - |
| 5 y5 years | +158.8% | - |
OKUR Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +158.8% | at high | +225.7% |
| 5 y | 5-year | at high | +158.8% | at high | +225.7% |
| alltime | all time | at high | +158.8% | at high | +225.7% |
OnKure Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $60.69 M(+225.7%) |
| Jun 2024 | - | $18.63 M(-3.2%) |
| Mar 2024 | - | $19.25 M(-35.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | - | $29.88 M |
| Dec 2023 | $29.88 M(+158.8%) | - |
| Dec 2022 | $11.54 M | - |
FAQ
- What is OnKure Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for OnKure Therapeutics?
- What is OnKure Therapeutics annual cash & cash equivalents year-on-year change?
- What is OnKure Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for OnKure Therapeutics?
What is OnKure Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of OKUR is $29.88 M
What is the all time high annual cash & cash equivalents for OnKure Therapeutics?
OnKure Therapeutics all-time high annual cash & cash equivalents is $29.88 M
What is OnKure Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, OKUR annual cash & cash equivalents has changed by +$18.33 M (+158.82%)
What is OnKure Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of OKUR is $60.69 M
What is the all time high quarterly cash and cash equivalents for OnKure Therapeutics?
OnKure Therapeutics all-time high quarterly cash and cash equivalents is $60.69 M